Lixte Biotechnology Inc. (LIXT)
1.33
0.03 (2.31%)
At close: Mar 03, 2025, 3:58 PM
1.21
-9.02%
After-hours: Mar 03, 2025, 03:59 PM EST
Lixte Biotechnology Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 |
| Net Income | -5.09M | -6.31M | -6.73M | -3.26M | -2.44M | -2.13M | -1.81M | -2.13M | -2.85M | -2.77M | -1.37M | -3.58M | -2.07M | -880.25K | -1.55M | -1.27M | -1.65M | -488.08K | -32.87K |
| Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 128.00 | 615.00 | 592.00 | 462.00 | n/a |
| Stock-Based Compensation | 773.2K | 1.55M | 2.6M | 1.25M | 748.65K | 785.61K | 70.69K | 287.16K | 549.7K | 946.17K | 119.25K | 1.02M | 204.9K | 160.71K | 745.98K | 571.05K | 890.44K | n/a | n/a |
| Other Working Capital | 94.54K | 150.96K | -49.11K | -164.62K | 69.2K | -46.7K | 173.1K | -65.51K | 66.38K | -267.4K | 48.13K | -88.09K | 221.58K | -228.88K | 58.79K | 67.43K | -38.21K | n/a | n/a |
| Other Non-Cash Items | n/a | 1.54M | 2.56M | 1.19M | 814.68K | 902.43K | -81.74K | 87.16K | 205.77K | 437.11K | 119.25K | 1.47M | 200.82K | 67.22K | 132.93K | 571.05K | 941.28K | 97.4K | n/a |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -571.05K | -890.44K | n/a | n/a |
| Change in Working Capital | 20.56K | 154.76K | -13.44K | -117.88K | 17.54K | -163.52K | 325.54K | 170.13K | -84.49K | -252.64K | 75.49K | -117.01K | 302.58K | -284.08K | 33.85K | 102.17K | 3.75K | -53.23K | n/a |
| Operating Cash Flow | -4.29M | -4.61M | -4.14M | -2.13M | -1.67M | -1.51M | -1.41M | -1.68M | -2.18M | -1.64M | -1.18M | -1.21M | -1.36M | -936.39K | -638.44K | -597.69K | -702.87K | -443.45K | -32.87K |
| Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -272 | -498 | n/a |
| Acquisitions | n/a | 5.14M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -207.56K | n/a | n/a | n/a | -1.58M | -25K | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 3.14M | n/a | n/a | n/a | n/a | n/a | n/a | 104.09K | 109.6K | n/a | n/a | 345K | n/a | 1.09M | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 104.09 | 109.6K | -207.56 | -1 | 345.00 | 1.25M | -1.09M | -25K | n/a | -272 | n/a | n/a |
| Investing Cash Flow | n/a | 5.14M | n/a | n/a | n/a | n/a | n/a | 104.09K | 109.6K | -207.56K | -1 | 345K | 1.25M | -1.58M | -25K | n/a | -272 | -498 | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.09M | 1.11M | 100K | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -112.95K | n/a | -118.68K | -214.52K | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2K | -2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 6.32K | n/a | 207.63K | n/a | n/a | -21.7K | 18K | 1.75M | 2.05M | 1.41M | 2.5M | 2.5M | 5K | n/a | 1.2M | n/a | n/a | 149.27K | 12.5K |
| Financial Cash Flow | 3.14M | 5.14M | 3.9M | 4.6M | n/a | 4.48M | 2.52M | 1.75M | 2.05M | 1.41M | 2.5M | 2.5M | 5K | 1.09M | 2.2M | 100K | 531.57K | 1.12M | 37.5K |
| Net Cash Flow | -1.15M | 529.65K | -245.52K | 2.47M | -1.67M | 2.97M | 1.11M | 174.65K | -19.13K | -430.61K | -1.18M | 1.64M | -104.79K | -1.42M | 1.53M | -497.69K | -171.57K | 674.69K | 4.63K |
| Free Cash Flow | -4.29M | -4.61M | -4.14M | -2.13M | -1.67M | -1.51M | -1.41M | -1.68M | -2.18M | -1.64M | -1.18M | -1.21M | -1.36M | -936.39K | -638.44K | -597.69K | -703.14K | -443.95K | -32.87K |